IL6 and Parkinson disease: Although direct evidence for hypomethylation of the promoters of IL-1β and Il-6 in PD is not as extensively detailed as for TNF-α, the general principle that hypomethylation drives increased expression of these cytokines in inflammatory contexts strongly suggests a similar mechanism in PD.